Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Traxion Sab De Cv Ord Shs GRPOF

Grupo Traxion SAB de CV is a Mexico-based company engaged in the transportation sector. The Company provides logistics services within eight business areas: Fright, including intermodal and multimodal services, door-to-door, national and cross-border distribution, among others; Integrated logistics, including logistics management, aerial and maritime services and custom transportation support services; Warehousing, including dedicated storage, shared warehouses, packing and value-added services, such as labeling and products assembly; Logistics systems, including software for logistics management; Passenger transportation, including transportation of personnel and students; Special services, including rental of bus and vans; Moving, including national and international moving services, and Advertising, including custom transportation services during marketing campaigns. The Company operates through a number of group companies.


PINL:GRPOF - Post by User

Post by JoeRoganBNNon Oct 31, 2017 8:27am
114 Views
Post# 26880443

DIN# Key to Large Growth.

DIN# Key to Large Growth.People, let’s all agree the main catalyst for tetra’s short to medium term growth is the issuance of PrinceptsRx.  If sales are good with Aphria and results are shown to be effective in patients, the stock will jump like never before.  I’m talking New 52-week highs over
night.  Peoplr who try and short this stock will lose out at some point. Based on what I’m seeing for tier 2/3 data, those selling at a loss are being gobbled up.
Make no mistake, lots of money is waiting on the sidelines to buy out those who can’t stomach volatility.  Anyone who’s ever bought bio tech companies are aware that it takes time to come to fruition. I’ve been around long enough to realize it. You need to believe in the company and its goals, otherwise what are you doing here...I do know that studies have been conducted in the past (with lower CBD and THC level marijuana) that has reduced pain in sufferers from 7/10 to 5.5/10 on average. a modest but significant improvement. However, today’s levels are double that and I can only assume the same test would result in sufferers having even less pain or discomfort. These trials will show their benefit. If this were the case then there is nothing to fear, as it’s a waiting game.
 

<< Previous
Bullboard Posts
Next >>